Welcome to World Journal of Gastrointestinal Oncology


The World Journal of Gastrointestinal Oncology (WJGO) is a leading academic journal devoted to reporting the latest, cutting-edge research progress and findings of basic research and clinical practice in the field of gastrointestinal oncology.  It was launched on October 15, 2009 and is published monthly (12 issues annually) by BPG, the world's leading professional clinical medical journal publishing company.


We encourage gastrointestinal oncologists worldwide to submit manuscripts to the WJGO describing their original basic or clinical research findings that are of high academic value and which report new diagnostic techniques or summarize their treatment experiences.


The usual times related to all publication processes of the WJGO are as follows: (1) From manuscript receipt to peer-review: 2-4 weeks; (2) From initial manuscript acceptance, with revisions, to return of the revised manuscript from the authors: 4-5 weeks; (3) From return of the revised manuscript from the authors to final acceptance: 1-2 weeks; (4) From final acceptance to an article in press: 2 days; and (5) From article in press designation to formal release of the electronic version and all online documentation: 2-9 weeks. The WJGO’s acceptance rate: 46%.  Submit here >>

Published Issues
1 2 3 4 5

Hsin-Chen Lee, PhD, Professor; Dimitrios Roukos, MD, PhD, Professor


PubMed, PubMed Central.

Journal Metrics

There is currently no impact factor.


1948-5204 (online)

Previous  |   Next  |   Latest  |   Archive
Contents Volume 8  Issue 5  May 15, 2016
Topic Highlight
MicroRNA in rectal cancer  
Azadeh Azizian, Jens Gruber, B Michael Ghadimi, Jochen Gaedcke
World J Gastrointest Oncol 8(5):416-426. Published online May 15, 2016. doi: 10.4251/wjgo.v8.i5.416
Role of Raman spectroscopy and surface enhanced Raman spectroscopy in colorectal cancer  
Cerys A Jenkins, Paul D Lewis, Peter R Dunstan, Dean A Harris
World J Gastrointest Oncol 8(5):427-438. Published online May 15, 2016. doi: 10.4251/wjgo.v8.i5.427
Current adjuvant treatment modalities for gastric cancer: From history to the future  
Leyla Kilic, Cetin Ordu, Ibrahim Yildiz, Fatma Sen, Serkan Keskin, Rumeysa Ciftci, Kezban Nur Pilanci
World J Gastrointest Oncol 8(5):439-449. Published online May 15, 2016. doi: 10.4251/wjgo.v8.i5.439
Multitarget stool DNA for colorectal cancer screening: A review and commentary on the United States Preventive Services Draft Guidelines  
Barry M Berger, Bernard Levin, Robert J Hilsden
World J Gastrointest Oncol 8(5):450-458. Published online May 15, 2016. doi: 10.4251/wjgo.v8.i5.450
Urinary metabolites as noninvasive biomarkers of gastrointestinal diseases: A clinical review  
Irene Sarosiek, Rudolf Schicho, Pedro Blandon, Mohammad Bashashati
World J Gastrointest Oncol 8(5):459-465. Published online May 15, 2016. doi: 10.4251/wjgo.v8.i5.459
Non-surgical factors influencing lymph node yield in colon cancer  
Patrick Wood, Colin Peirce, Jurgen Mulsow
World J Gastrointest Oncol 8(5):466-473. Published online May 15, 2016. doi: 10.4251/wjgo.v8.i5.466
Retrospective Study
Intensity modulated radiation therapy with simultaneous integrated boost based dose escalation on neoadjuvant chemoradiation therapy for locally advanced distal esophageal adenocarcinoma  
Ming Zeng, Fernando N Aguila, Taral Patel, Mark Knapp, Xue-Qiang Zhu, Xi-Lin Chen, Phillip D Price
World J Gastrointest Oncol 8(5):474-480. Published online May 15, 2016. doi: 10.4251/wjgo.v8.i5.474